EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 82 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,296 | -82.0% | 20,640 | -58.5% | 0.00% | – |
| Q2 2023 | $35,003 | -75.9% | 49,720 | -69.4% | 0.00% | – |
| Q1 2023 | $145,539 | -8.4% | 162,269 | +20.5% | 0.00% | – |
| Q4 2022 | $158,842 | -84.7% | 134,612 | -2.4% | 0.00% | – |
| Q3 2022 | $1,038,000 | +40.5% | 137,927 | +17.6% | 0.00% | – |
| Q2 2022 | $739,000 | -26.5% | 117,266 | -3.2% | 0.00% | – |
| Q1 2022 | $1,005,000 | +53.2% | 121,110 | -4.3% | 0.00% | – |
| Q4 2021 | $656,000 | -21.2% | 126,597 | +1.4% | 0.00% | – |
| Q3 2021 | $833,000 | -15.3% | 124,856 | +8.1% | 0.00% | – |
| Q2 2021 | $984,000 | +7.1% | 115,483 | +11.2% | 0.00% | – |
| Q1 2021 | $919,000 | -28.4% | 103,848 | -0.6% | 0.00% | – |
| Q4 2020 | $1,284,000 | +67.2% | 104,498 | +10.7% | 0.00% | – |
| Q3 2020 | $768,000 | -12.6% | 94,373 | +3.0% | 0.00% | – |
| Q2 2020 | $879,000 | +68.4% | 91,626 | +19.3% | 0.00% | – |
| Q1 2020 | $522,000 | -53.9% | 76,783 | +0.9% | 0.00% | – |
| Q4 2019 | $1,133,000 | +48.9% | 76,085 | +2.6% | 0.00% | – |
| Q3 2019 | $761,000 | -1.2% | 74,159 | +2.0% | 0.00% | – |
| Q2 2019 | $770,000 | +134.0% | 72,712 | +209.4% | 0.00% | – |
| Q1 2019 | $329,000 | +64.5% | 23,504 | +19.3% | 0.00% | – |
| Q4 2018 | $200,000 | -16.3% | 19,697 | -1.1% | 0.00% | – |
| Q3 2018 | $239,000 | -4.0% | 19,919 | -2.4% | 0.00% | – |
| Q2 2018 | $249,000 | +69.4% | 20,412 | +36.8% | 0.00% | – |
| Q1 2018 | $147,000 | -26.1% | 14,920 | +4.7% | 0.00% | – |
| Q4 2017 | $199,000 | +24.4% | 14,257 | -2.1% | 0.00% | – |
| Q3 2017 | $160,000 | +39.1% | 14,567 | 0.0% | 0.00% | – |
| Q2 2017 | $115,000 | -26.8% | 14,567 | +6.4% | 0.00% | – |
| Q1 2017 | $157,000 | +3.3% | 13,696 | +4.7% | 0.00% | – |
| Q4 2016 | $152,000 | -7.9% | 13,082 | +6.2% | 0.00% | – |
| Q3 2016 | $165,000 | -22.9% | 12,319 | +14.3% | 0.00% | – |
| Q2 2016 | $214,000 | – | 10,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $6,144,000 | 4.00% |
| P.A.W. CAPITAL CORP | 380,000 | $3,363,000 | 2.96% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $6,770,000 | 1.78% |
| Telemetry Investments, L.L.C. | 150,477 | $1,332,000 | 1.51% |
| 683 Capital Management, LLC | 2,683,600 | $23,750,000 | 1.26% |
| KNOTT DAVID M | 276,535 | $2,447,000 | 1.05% |
| Trellus Management Company, LLC | 226,000 | $2,000,000 | 1.04% |
| TOWERVIEW LLC | 140,000 | $1,239,000 | 0.77% |
| Vivo Capital, LLC | 1,791,257 | $15,853,000 | 0.56% |
| CAXTON CORP | 94,083 | $833,000 | 0.54% |